Healthcare for All Lead Image
Healthcare for All Lead Image

Mlolongo Blue Box Clinic, Kenya.

Better Health for All
Better Health for All
GRI
  • J&J19-10
    Total investment in R&D

Innovating for Better Health

Over the past 130 years, we’ve learned a lot about how to innovate and adapt to evolving health needs—from surgical breakthroughs, to tear-free shampoo, to modern treatments for HIV/AIDS and tuberculosis. That knowledge and experience informs our innovation, which is motivated by the need to find solutions for everyday health challenges and life-threatening conditions; answers to new health threats as they emerge; and access to medicines, treatment and care for all. With our global reach comes a responsibility and a unique ability to leverage our deep expertise and extensive partnerships to unlock the full potential of science and technology to improve health and wellbeing in response to these needs. Our progress is measured by the positive impact we have on the health—and lives—of people, communities and society in general. We hope to build a future where everyone’s best health is within reach.

We pursue breakthroughs in science and technology in our own laboratories and through our powerful network of scientists and entrepreneurs all over the world. The diagram to the right shows our innovation vision and four innovation approaches across our three business segments.

Innovation vision chart2
  • 200
    active collaborations and partnerships— from discovery to late-stage pharmaceutical R&D development
  • $11.4
    billion invested in R&D in 2019, an increase of 5.4% over 2018
  • 17.6%
    of Johnson & Johnson employees involved in R&D activities11

11 Includes employees classified under job functions of R&D and Engineering.

You are leaving jnj.com and entering a third-party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties.
Continue